Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patient

Abstract

A patient is described whose output from an enterocutaneous fistula was greatly reduced using octreotide, a somatostatin analogue.

Keywords

case report diarrhoea intestinal fistula palliative treatment

Get full access to this article

View all access options for this article.

References

Pless J. , Bauer W. , Briner U. et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol 1986; 21 (suppl 119): 54-64.

Nightingale Jmd , Walker ER , Burnham WR et al. Short bowel syndrome. Digestion 1990; 45 (suppl 1): 77-83.

Jacobsen O. , Ladefoged K. , Stage JG , Jarnum S. Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 1986; 21: 824-28.

Ladefoged K. , Christensen KC , Hegnhoj J. , Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome . Gut 1989; 30: 943-49.

Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495-1501.

Nubiola Calonge P. , Sancho J. , Segura M. et al. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987; ii: 672-74.

Boden G. , Sivitz MC , Owen OE et al. Somatostatin suppresses secretin and pancreatic exocrine secretion . Science 1975; 160: 163-65.

Bloom SR , Mortimer CH , Thorner MO et al. Inhibition of gastrin and gastric acid secretion by GH-RIH. Lancet 1974; ii: 1106-1109.

Thor P. , Krol R. , Kontureck JJ et al. Effect of somatostatin on myoelectrical activity of small bowel . Am J Physiol 1978; 235: 249-54.